ANSWERS
IN MINUTES,
NOT DAYS
Bioeureka™ designs rapid diagnostic tools that deliver the result where the decision is made. Our portfolio covers two fields: microbiology, with AIMO and MicroSelect, and maternal health, with DETRHO.
In development · Not yet licensed for clinical use
About us
Boost Efficiency, and maximize your profits with intelligent AI solutions.
Bioeureka™ develops rapid diagnostic solutions that help public and private organizations cut testing costs and make better decisions.
In microbiology, our AI platform AIMO, paired with our proprietary MicroSelect culture medium, turns pathogen and microorganism testing into a fast, reliable and cost-effective digital workflow for the food, pharmaceutical and clinical diagnostic sectors.
In maternal health, we are developing DETRHO, a rapid test designed to detect anti-D antibodies during the prenatal visit.
In development · Not yet licensed for clinical use
The idea is the same in both fields: a reliable result, where the decision is made, without depending on an outside lab.
SERVICES AND PRODUCTS
Endless innovation starts here.
Bioeureka™ designs rapid diagnostic tools that deliver the result where the decision is made. Our portfolio covers two fields: microbiology, with AIMO and MicroSelect, and maternal health, with DETRHO.
In development · Not yet licensed for clinical use
Microbiology and food safety
AIMO
Artificial Intelligence for Micro Organisms
AIMO is our AI platform dedicated to microbiological image recognition. Trained on millions of images of pathogens and microorganisms, it identifies colonies within seconds after incubation, with accuracy above 95%. AIMO automatically generates an audit-ready report with a confidence score and integrates with your existing quality procedures.
MicroSelect™
MicroSelect is our optimized culture medium for fast, reliable microbial selection. Designed to work hand in hand with AIMO, it shortens culture time and improves the quality of the image analyzed by the AI. Together, AIMO and MicroSelect form the first integrated software-and-consumable platform dedicated to food safety and applied microbiology.
Maternal health
DETRHO In development
Anti-D screening during the prenatal visit
DETRHO is a rapid strip test designed to detect anti-D antibodies in a drop of blood in 2 to 3 minutes. It shows whether an Rh-negative pregnant woman is already immunized against her baby’s Rh factor, with no reader and no lab. DETRHO is currently being validated and is not yet licensed for clinical use.
Discover DETRHO →Partner with us on validation ↗Concept visual in development
In development · Not yet licensed for clinical use
DETRHO is an in vitro diagnostic device in development. It is not licensed by Health Canada or any other regulatory authority and is not offered for sale or for clinical use.
OUR VALUES
Strong principles that guide every innovation and reinforce confidence in our solutions.
Responsible
innovation
We innovate with scientific rigour and uncompromising ethics to deliver solutions that are genuinely useful and reliable.
Collaboration
We work alongside our partners and clients to build tools that serve the common good.
Accountability
We are mindful of the impact our technologies have on public health and act consistently to protect the people we serve.
Integrity and
confidentiality
We safeguard data security, transparency, and scientific credibility in everything we do.
FAQ
Frequently Asked Questions
How long does it take to get a result with the AIMO technology?
After the incubation period (12-24 hours), AI analysis produces a result within minutes. You no longer have to wait the usual 2 to 5 days for a reference laboratory.
Do I need to change my current equipment to use AIMO?
No. Our solution is compatible with standard microscopes and cameras already present in most laboratories. No upfront investment is required if you have a microscope, camera and computer.
Which pathogens and microorganisms are covered?
AIMO’s library covers the main pathogens of interest in the food and clinical sectors, including E. coli, Salmonella, Listeria, Campylobacter, yeasts, and moulds. The library is continuously expanded as we train our AI models.
How does Bioeureka™ reduce testing costs?
By automating identification and eliminating the need to ship samples to an external lab, Bioeureka™ brings the cost per test down from $43–$72 to $4.99. Labour savings come from accuracy above 95%, which virtually eliminates retesting.
Is the platform compliant with regulatory standards?
Yes. AIMO is aligned with ISO, USP, and EP standards in microbiology. Image traceability, audit logs, and standard operating procedures (SOPs) are built in. HIPAA and SOC 2 certifications are in progress for expansion markets.
How do I get started with AIMO?
You can take advantage of 500 free analyses per month under our freemium model, with no commitment. A 30-day free trial is also available. Contact us to schedule a personalized demo.
Try it now
Try AIMO, our AI-powered pathogen identification technology, today with a free trial.
